Anzeige
Mehr »
Login
Montag, 03.02.2025 Börsentäglich über 12.000 News von 685 internationalen Medien
Die Robotik-Revolution, von der Forscher sagen, sie wird den gesamten US-Aktienmarkt in den Schatten stellen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 863195 | ISIN: FR0000121667 | Ticker-Symbol: ESL
Tradegate
03.02.25
14:04 Uhr
263,40 Euro
-1,70
-0,64 %
1-Jahres-Chart
ESSILORLUXOTTICA SA Chart 1 Jahr
5-Tage-Chart
ESSILORLUXOTTICA SA 5-Tage-Chart
RealtimeGeldBriefZeit
263,60263,7014:09
263,60263,7014:09
GlobeNewswire (Europe)
78 Leser
Artikel bewerten:
(0)

EssilorLuxottica receives FDA clearance and EU certifications for Nuance Audio, making it available to consumers in the U.S. and Europe

Finanznachrichten News

EssilorLuxottica receives FDA clearance and EU certifications for Nuance Audio, making it available to consumers in the U.S. and Europe

Paris, France (3 February 2025) - EssilorLuxottica announced today that it has received clearance from the Food and Drug Administration (FDA) for its OTC Nuance Audio Glasses. The Group has simultaneously achieved the CE marking under the Medical Devices Regulation in the EU, alongside the development of an ISO Quality Management System certification dedicated to Hearing Aids, which will allow Nuance Audio to launch in Europe.

Paving the way for a disruptive new category in the med-tech space, Nuance Audio Hearing Aid Software is the first FDA cleared, preset Software as Medical Device (SaMD) in the U.S. It delivers a groundbreaking open-ear hearing solution seamlessly integrated into a pair of stylish smart glasses. After decades of adoption barriers ranging from comfort to visibility, consumers will finally be able to see clearly and hear clearly with a single product that is both beautiful and highly functional.

Nuance Audio will be available for purchase in the U.S. beginning in Q1. In the first half of 2025, it will be available in certain European countries, including France, Germany and UK, starting progressively from Italy in Q1, in parallel with U.S. market.

As part of EssilorLuxottica 's open business model, the Group will leverage its extensive retail network, while also engaging both traditional audiology practices and optical wholesale customers to make this technology accessible to consumers wherever possible.

"Two years ago, we set out to create a first-of-its-kind product that would change the way people see and hear. We didn't just aim to combine two medical devices - we created an entirely new smart glasses form factor to support the two human senses we depend on the most. It is not only groundbreaking, but also incredibly accessible. We're pleased now to turn our focus to getting this life-changing technology into the hands of people around the world who truly need it," said Francesco Milleri, Chairman and CEO of EssilorLuxottica.

The global hearing solutions market remains underserved, much like the vision market decades ago, where consumers are often hesitant to wear corrective devices due to factors such as stigma, discomfort, cost, and limited accessibility. Nuance Audio seeks to overcome these barriers, which have hindered the widespread adoption of traditional hearing aids. With the introduction of Nuance Audio Glasses, the company aims to meet the needs of approximately 1.25 billion1 people worldwide who experience mild to moderate hearing loss.

Notes:
1 World Health Organization, World Report on Hearing, 2021, p. 40.


© 2025 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.